NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Alloplex Biotherapeutics

Alloplex Biotherapeutics

Private
Woburn, MassachusettsHealthcare & Life Scienceshttps://alloplexbio.com/

Last Round

Series A

Feb 1, 2023

Total Funding Raised

$16M

Company Overview

Alloplex Biotherapeutics is a biotechnology company that develops autologous, non-engineered cellular therapies for the treatment of cancer and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cellular immunotherapyautologous cell therapysolid tumor treatmentnon-engineered cell therapyimmune cell trainingcancer immunotherapyex vivo activationPBMC therapynext-gen immunotherapybiotech licensingcell therapy manufacturingoncology R&Doff-the-shelf alternative

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alloplex Biotherapeutics Comparables

Compare Alloplex Biotherapeutics with similar companies based on industry and business-model similarity.

Alloplex Biotherapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Marker Therapeutics Inc
74%
Acepodia
74%
Iovance Biotherapeutics
69%

Alloplex Biotherapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 1, 2023
Corporate FundingDec 15, 2021
Corporate FundingAug 19, 2021
AngelJul 24, 2019

Key People

Founding team and executive leadership

Frank Borriello

CEO

Executive Team

Alloplex Biotherapeutics Investors

Notable investors and investment history

Alloplex Biotherapeutics investors
InvestorRounds
The Wells InvestmentSeries A
Keiretsu ForumSeries A
Hackensack Meridian HealthCorporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2023

    $15M round led by The Wells Investment

  • Aug 19, 2021

    $1M raised from Daewoong Pharmaceutical and Hanall Biopharma.

Alloplex Biotherapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Alloplex Biotherapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Alloplex Biotherapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersWoburn, Massachusetts
Employee Range5
Year Founded2016
Last FundingFeb 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.